Description

Epilepsy, Part II, Treatment, Volume 108, provides a full description of epilepsy pathology and etiology, antiepileptic drug treatment, the approach to surgical evaluation and alternative procedures to be considered, in both children and adults, as well as brain stimulation and diet treatment. Economic and psychosocial issues such as stigma are fully covered. The special problems of epilepsy treatment in the developing world are described. Chapters are authored by internationally respected neurologists with varied perspectives insuring depth to the content. Epilepsy, Part I, Basic Principles and Diagnosis, Volume 107, establishes the scientific and practical diagnosis of epilepsy. The volumes will be a very important resource for basic scientists, clinical investigators, and all health professionals treating patients with epilepsy.

Key Features

*A volume in the Handbook of Clinical Neurology series, which has an unparalleled reputation as the world's most comprehensive source of information in neurology.
*International list of contributors including the leading workers in the field.
*Describes the advances which have occurred in clinical neurology and the neurosciences, their impact on the understanding of neurological disorders and on patient care.

Readership

Clinical neurologists and research neuroscientists

Table of Contents

SECTION 3  ETIOLOGIES OF EPILEPSY
30. Metabolic and degenerative disorders - T. Granata (Milan, Italy)
31. Neurocutaneous syndromes - G. Kurlemann (Münster, Germany)
32. Cortical malformations - R. Spreafico and L. Tassi (Milan, Italy)
33. Epilepsy associated brain tumors - I. Blümcke (Erlangen, Germany)
34. Seizures after stroke - A. Guekht and N.M. Bornstein (Moscow, Russia and Tel Aviv, Israel)
35. Posttraumatic epilepsy - A. Martins Da Silva and L.J. Willmore (Porto, Portugal and St Louis, USA)
36. Infection and inflammation - H.H. Garcia and O.H. Del Brutto (Lima, Peru and Guayaquil, Ecuador)
37. Hippocampal sclerosis - Ç. Özkara and  E. Aronika (Istanbul, Turkey and Amsterdam, the Netherlands)
SECTION 4  TREATMENT
38. Natural course of epilepsies - L. Forsgren and M. Sillanpää (Umeå, Sweden and Turku, Finland)
39. Mechanisms of action of antiseizure drugs - R.J. Porter, A. Dhir, R.L. MacDonald and M.A. Rogawski (Bethesda, Davis and Nashville, USA)
40. Principles of drug treatment in adults - T. Tomson and B.J. Steinhoff (Stockholm, Sweden and Kehl-Kork, Germany)
41. Principles of drug treatment in children - M.A. Mikati, M. Nabulsi Khalil and S.U. Steele (Durham, USA and Beirut, Lebanon)
42. Antiepileptic drugs: advantages and disadvantages - B. Abou-Khalil and D. Schmidt (Nashville, USA and Berlin, Germany)
43. Pharmacoresistance - H. Potschka and M.J. Brodie (Munich, Germany and Glasgow, UK)
44. Gender issues - P. Crawford and S. Duncan (York and Edinburgh, UK)
45. Ketogenic diet - R.H. Caraballo and E. Vining (Buenos Aires, Argentina and Baltimore, USA)
46. Status epilepticus in children - K. Holland and S. Shinnar (Cincinnati and Bronx, USA)
47. Status epilepticus – adults - F. Rosenow and S. Knake (Marburg, Germany)
48. Who is a surgical candidate? - J. Engel and S. Wiebe (Los Angeles, USA and Calgary, Canada)
49. Pre-operative evaluation in chi

Details

No. of pages:
608
Language:
English
Copyright:
© 2012
Published:
Imprint:
Elsevier
Print ISBN:
9780444528995
Electronic ISBN:
9780444535061

About the editors

Hermann Stefan

Affiliations and Expertise

Director of Epilepsy Centre, Neurological Clinic, University Hospital, Erlangen, Germany

William Theodore

Affiliations and Expertise

Clinical Epilepsy Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, and Uniformed Services University of the Health Sciences, Bethesda, MD, USA